التفاصيل البيبلوغرافية
| العنوان: |
Fasting lipids and anticardiolipin antibodies as risk factors for vascular disease in systemic lupus erythematosus. |
| المؤلفون: |
MacGregor, A J, Dhillon, V B, Binder, A, Forte, C A, Knight, B C, Betteridge, D J, Isenberg, D A |
| المصدر: |
Annals of the Rheumatic Diseases; Feb1992, Vol. 51 Issue 2, p152-155, 4p, 3 Diagrams, 3 Charts |
| مستخلص: |
Fasting cholesterol, triglyceride, low density lipoprotein cholesterol, high density lipoprotein cholesterol, apoprotein AI, and apoprotein B were measured in 64 patients with systemic lupus erythematosus to assess the risk factors for vascular disease. The relation between the lipid profile, steroid treatment, the presence of anticardiolipin antibodies, and the prevalence of vascular disease was examined. Raised concentrations of triglyceride and apoprotein B were seen in those patients treated with more than the equivalent of 10 mg prednisolone a day in the six months before testing. An increase in vascular disease was found only in the subgroup of patients with increased triglycerides who also expressed anticardiolipin antibodies. This study confirms the association between treatment with high doses of steroids in lupus and the development of an atherogenic plasma lipid profile. The presence of anticardiolipin antibodies compounds the risk of developing vascular disease. [ABSTRACT FROM PUBLISHER] |
|
Copyright of Annals of the Rheumatic Diseases is the property of BMJ Publishing Group and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
